• Hematolymphoid Neoplasm Gene Mutation Panel, NGS
  • B-cell Activating Factor Receptor (BAFF-R), Flow Cytometry
  • Biopsy, Colon
  • Valproic Acid, Total, Serum
  • Ascorbic Acid (Vitamin C)
  • Methylmalonic Acid (MMA), Quantitative, Urine
  • Hereditary Erythrocytosis Gene Mutation Panel, NGS
  • SMAD4 Germline Mutation Analysis
  • Buspirone, Urine
  • Comprehensive Mitochondrial Disorders Gene Analysis Panel, NGS (Genomic Unity®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /The BT-Reveal Early Pancreatic Cancer Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

The BT-Reveal Early Pancreatic Cancer Test
Medical Test

Diseases (2)
Access to The BT-Reveal Early Pancreatic Cancer Test is restricted.
Loading...